TNF Pharmaceuticals Inc [TNFA] Revenue clocked in at $0.00 million, down -80.83% YTD: What’s Next?

TNF Pharmaceuticals Inc [NASDAQ: TNFA] traded at a high on Wednesday, posting a 23.39 gain after which it closed the day’ session at $0.22.

The results of the trading session contributed to over 14891928 shares changing hands. Over the past one week, the price volatility of TNF Pharmaceuticals Inc stands at 14.43% while the volatility over the past one month is 14.39%.

The market cap for TNFA stock reached $2.23 million, with 10.13 million shares outstanding and 9.63 million shares in the current float. Compared to the average trading volume of 1.54M shares, TNFA reached a trading volume of 14891928 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about TNF Pharmaceuticals Inc [TNFA]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNFA shares is $32.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNFA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

The Average True Range (ATR) for TNF Pharmaceuticals Inc is set at 0.03 The Price to Book ratio for the last quarter was 0.08, with the Price to Cash per share for the same quarter was set at 0.84.

How has TNFA stock performed recently?

TNF Pharmaceuticals Inc [TNFA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 14.49. With this latest performance, TNFA shares dropped by -18.45% in over the last four-week period, additionally sinking by -83.54% over the last 6 months – not to mention a drop of -91.18% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNFA stock in for the last two-week period is set at 46.24, with the RSI for the last a single of trading hit 54.76, and the three-weeks RSI is set at 41.21 for TNF Pharmaceuticals Inc [TNFA]. The present Moving Average for the last 50 days of trading for this stock 0.2909, while it was recorded at 0.1964 for the last single week of trading, and 1.0702 for the last 200 days.

TNF Pharmaceuticals Inc [TNFA]: Deeper insight into the fundamentals

TNF Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.40.

Insider trade positions for TNF Pharmaceuticals Inc [TNFA]

There are presently around $4.41%, or 4.41%% of TNFA stock, in the hands of institutional investors.